1. Lipton RB, Stewart WF, Von Korff M. Burden of migraine: Societal costs and therapeutic opportunities. Neurology 1997;48(S3):S4-S9.
2. Headache classification committee of the international headache society. Classification and diagnostic criteria for headche disorders, cranial neuralgia, and facial pain. Cephalagia 1988;8:1-96.
3. Headache classification committee. The international classification of Headache disorders, 2nd edition. Cephalagia 2004;24:1-160.
4. Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartate. Arch Neurol Psychiatry 1938;39:737-763.
5. The guideline of migraine. korean J Headache 2008;2nd ed. Seoul: 1-97.
6. Kim BK. Pathophysiological basis of migraine therapy. Korean J Headache 2005;6:6-13.
7. Silberstein SD. Migraine The Lancet 2004;363:381-391.
8. Filippi M, Rocca MA. Headche and migraine. Neurol Sci 2008;29:S336-S338.
9. Moon HS. Acute treatment of migraine:triptans and beyond. Korean J headache 2005;6:14-20.
10. Aguggia M. Treating headaches with botulinum toxin. Neurol Sci 2008;29:S137-S139.